Differential effects of sertraline and cognitive behavioural therapy on behavioural inhibition in patients with obsessive compulsive disorder [0.03%]
舍曲林与认知行为疗法对强迫症患者行为抑制的差异性影响研究
Jemma E Reid,Luca Pellegrini,Lynne Drummond et al.
Jemma E Reid et al.
Patients with obsessive compulsive disorder (OCD) randomised to sertraline, manualised cognitive behavioural therapy (CBT), or combination (sertraline + CBT), underwent cognitive assessment. Cognitive testing was conducted at baseline and a...
Stroke, COVID-19, and other somatic aspects of psychiatric disorders treatments [0.03%]
卒中、新冠肺炎及其它躯体疾病对精神疾病的治疗作用
Alessandro Serretti
Alessandro Serretti
Recent updates on treatment patterns in patients with treated attention-deficit/hyperactivity disorders from a nationwide real-world database in South Korea [0.03%]
来自韩国全国真实世界数据库的ADHD患者治疗模式的最新更新
Yoon Cho,Ah-Young Kim,Sukhyang Lee et al.
Yoon Cho et al.
The prevalence of attention-deficit/hyperactivity disorder (ADHD) is steadily increasing across Korea. We analyzed ADHD patients with ADHD medications (Rx) characteristics and treatment patterns compared to patients without Rx and identifie...
Toshinori Nakamura,Yusuke Arai,Tetsuya Hagiwara et al.
Toshinori Nakamura et al.
Lemborexant, an orexin receptor antagonist, is effective not only for sleep disorders but also for preventing and treating delirium. To date, no complex sleep-related behaviors due to lemborexant have been reported. Herein, we present the c...
Evaluating the influence of nonproblematic alcohol intake on the outcome of major depression [0.03%]
评估非问题性酒精摄入对主要抑郁症状结果的影响
Víctor Navarro,Joana Guarch,Ilham Boulahfa et al.
Víctor Navarro et al.
The effect of light or moderate alcohol intake on the outcome of patients with major depression taking antidepressants is a question that remains unanswered. The main objective of this study was to assess the association between light or mo...
Metabolic syndrome and its relation to antipsychotic polypharmacy in schizophrenia, schizoaffective and bipolar disorders [0.03%]
精神分裂症，双相障碍和情感性精神病患者的代谢综合症及其与使用多种抗精神病药物的关系
Karim Abdel Aziz,Hind Mohd Ahmed,Emmanuel Stip et al.
Karim Abdel Aziz et al.
The risk of metabolic syndrome (MetS) has been attributed to antipsychotic use in psychiatric patients. To date, there is limited data on the relationship between antipsychotic polypharmacy and MetS in patients with schizophrenia, schizoaff...
Towards a replicable protocol to identify patients with psychiatric disorders at higher risk of developing dementia [0.03%]
识别出发展为痴呆症高风险的精神障碍患者的可复制方案研究进展
Veronika Matuskova,Martin Vyhnalek
Veronika Matuskova
Micronized/ultramicronized palmitoylethanolamide improves depression and fatigue in coronavirus disease 2019 (COVID-19) survivors [0.03%]
微粉化/超微粉化棕榈酰乙醇胺改善新冠病毒病（COVID-19）幸存者的抑郁和疲劳症状
Aurora Merolla,Rebecca De Lorenzo,Giacomo Paolazzi et al.
Aurora Merolla et al.
Coronavirus disease 2019 (COVID-19) may lead to neuropsychiatric sequelae. Palmitoylethanolamide (PEA) is an anti-inflammatory and neuroprotective amide used in depressive syndromes. Here we investigate whether micronized/ultramicronized (m...
Prospective, comparative, pilot study of maintenance treatment in comorbid bipolar disorders with post-traumatic stress disorder [0.03%]
伴随创伤后应激障碍的双相障碍维持治疗的前瞻性对比试点研究
Hernán F Guillen-Burgos,Juan F Gálvez-Flórez,Sergio Moreno-Lopez et al.
Hernán F Guillen-Burgos et al.
There is limited real-world evidence that evaluates the impact of monotherapy vs. combination therapy as a maintenance treatment in comorbid post-traumatic stress disorder (PTSD) in bipolar disorder (BD). Our aim was to compare lithium vs. ...
The impact of efficacy of long-acting injectable antipsychotics on caregivers' burden of patients with schizophrenia [0.03%]
长效注射抗精神病药物的疗效对精神分裂症患者照护者负担的影响
Enrico Capuzzi,Cecilia Quitadamo,Alice Caldiroli et al.
Enrico Capuzzi et al.